Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain

Trial Profile

Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs Tivanisiran (Primary)
  • Indications Dry eyes; Ocular pain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Sylentis
  • Most Recent Events

    • 14 Mar 2016 Results and additional analysis of this clinical trial will be presented at the ARVO conference in May 2016, according to a Sylentis media release.
    • 14 Mar 2016 Results published in a Sylentis media release.
    • 22 May 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top